Octreotide treatment increases exercise capacity in patients with acromegaly

European Journal of Endocrinology

Volumn 134, Issue 5, 1996, Pages 554-559

  Padayatty, Sebastian J ^a,b   Perrins, Edward J ^a   Belchetz, Paul E ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FATIGUE; FEMALE; HEART OUTPUT; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029996565     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340554     Document Type: Article

References (29)

1. Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med 1970;39:1-16
2. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 1980;12:71-9
3. Bengtsson B-A, Eden S, Ernest I, Odén A, Sjögren B. Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988; 223:327-35
4. Savage DD, Henry WL, Eastman RC, Borer JS, Gorden P. Echocardiographic assessment of cardiac anatomy and function in acromegalic patients. Am J Med 1979;67:823-9
5. Smallridge RC, Rajfer S, Davia J, Schaaf M. Acromegaly and the heart, an echocardiographic study. Am J Med 1979;66:22-7
6. Hayward RP, Emanuel RW, Nabarro JD, Acromegalic heart disease: influence of the treatment of acromegaly on the heart. Q J Med New Ser 1987;237:41-58
7. Furlanetto RW. Pitfalls in the somatomedin-c radioimmunoassay. J Clin Endocrinol Metab 1982;52:1084-6
8. Bruce RA. Exercise testing of patients with coronary heart disease. Ann Clin Res 1971;3:323
9. Jette M, Sidney K, Blümchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol 1990;13:555-65
10. Hart TB, Radow SK, Blackard WG, Tucker H, Cooper KR. Sleep apnoea in active acromegaly. Arch Intern Med 1985;145:865-6
11. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-4
12. Foss MC, Saad MJ, Paccola GM, Paula FJ, Piccinata CE, Moreira AC. Peripheral glucose metabolism in acromegaly. J Clin Endocrinol Metab 1991;72:1048-53
13. Lamberts SW, Uitterlinden P, Verchoor L, Van Dongen KJ, del Pozo E. Long term treatment of acromegaly with somatostatin analogue SMS 201-995. N Eng J Med 1985;313:1576-80
14. Flyvberg A, Jörgensen KD, Marshall SM, Orskov H, Inhibitory effect of Octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats. Am J Physiol 1991:260(4 pt 1):E568-74
15. Tsuzaki S, Moses AC. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells. Endocrinology 1990;126:3131-8
16. Ezzat S, Ren S-G, Braunstein GD, Melmed S. Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action. J Clin Endocrinol Metab 1992;75:1459-63
17. Feek CM, McLelland J, Seth J, Toft AD, Irvine WJ, Padfield PL, et al. How effective is external pituitary irradiation for growth hormone-secreting pituitary tumours? Clin Endocrinol 1984;20: 401-8
18. Baldwin A, Cundy T, Butler J, Timmis AD. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Acta Endocrinol 1985;108:26-30
19. Hradec J, Marek J, Kral J, Janota T, Poloniecki J, Malik M. Long-term echocardiographic follow-up of acromegalic heart disease. Am J Cardiol 1993;72:205-10
20. Pereira JL, Rodriguez-puras MJ, Leal-Cerro A, Martinez A, Garcia-Luna PP, Gavilan I, et al. Acromegalic cardiopathy improves after treatment with increasing doses of Octreotide. J Endocrinol Invest 1991;14:17-23
21. Merola B, Cittadini A, Caolao A, Ferone D, Fazio S, Sabatini D, et al. Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. J Clin Endocrinol Metab 1993;77:790-3
22. Thuesen L, Christiansen JS, Sørensen KE, Jørgensen JO, Ørskov H, Henningsen P. Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. Dan Med Bull 1988;35:193-6
23. Thuesen L, Christensen SE, Weeke J, Ørskov H, Henningsen P. A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients? Acta Med Scand 1988;223:337-43
24. Erbas T, Erbas B, Usman A, Bekdik CF. Assessment of left ventricular dysfunction in acromegalic patients using radionuclide ventriculography parameters. Cardiology 1992;80:172-9
25. Courville C, Mason VR. The heart in acromegaly Arch Intern Med 1988;61:704-13
26. Fabian J, Stolz I, Jenota M, Rohac J. Reproducibility of exercise tests in patients with symptomatic ischaemic heart disease. Br Heart J 1975;37:785
27. Anon. Acromegalic heart disease. Lancet 1987:ii:254-5
28. O'Sullivan AJ, Kelly JJ, Hoffman DM, Freun D, Ho KKY. Body composition and energy expenditure in acromegaly Clin Endocrinol Metab 1994;78:381-6
29. O'Sullivan AJ, Kelly JJ, Hoffman DM, Baxter RC, Ho KKY. Energy metabolism and substrate oxidation in Acromegaly. J Clin Endocrinol Metab 1995;80:486-91